Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
4.540
-0.095 (-2.05%)
At close: Jun 13, 2025, 4:00 PM
4.760
+0.220 (4.85%)
After-hours: Jun 13, 2025, 4:01 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $2.65 million as of June 13, 2025. Its market cap has decreased by -75.37% in one year.
Market Cap
2.65M
Enterprise Value
2.02M
1-Year Change
-75.37%
Ranking
Category
Stock Price
$4.54
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $2.65M, a decrease of -99.18%. That is a compound annual growth rate of -74.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 2.70M | -71.06% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.73B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |